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Abstract 
Objective: To analyze the need for increased content on genomics in Public Health (PH) 
academic curriculum.    
Methods: A literature synthesis was performed of various genetic science studies.  Results were 
assessed with regard to the number and type of genomic studies published, cost to perform 
genetic analyses, health care provider and the public’s use and understanding of genetic testing 
capabilities.  A search was conducted and assessment performed of public health genomics 
curriculum at accredited public health educational programs.    
Results: The cost to sequence a single genome declined from $10 million in 2007 to under $10 
thousand in 2012.  This cost reduction correlates with an uptrend in published genome-wide 
association studies from about 50 published in 2007 to over 1300 published in 2012.  
Approximately 2000 genetic tests are currently available with applications relevant to 
environmental genetics, personalized medicine and reproductive trait testing.  A dearth of 
genetics-related material in academic PH programs is juxtaposed against current advancements 
in genetics.   
Conclusions: Public health professionals should learn and develop genomic science materials 
for health promotion and education and policy addressing today’s genetic determinants of health.  
A broad-based PH genomics course which introduces many issues versus deep details into a 
single genomics topic would address this need for the next generation of public health students 
and would be a valuable continuing education offering for current professionals.  The discussion 
includes recommendations related to a full spectrum of PH programs, to include smaller 
programs that may not be in a position to add a new focus of study.   
 Keywords: genetics, DNA, personalized medicine, pharmacogenomics, academia 
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Critical Analysis of Contemporary Public Health Genomics and Needs Assessment for 
Public Health Genomics Course Curriculum 
 The National Human Genome Project and genetic science research is rapidly increasing a 
variety of uses for human genetic information in medical treatment, environmental genetics 
health risk assessments, and reproductive selection of viable embryos in fertility treatment.  The 
Centers for Disease Control and Prevention has therefore dedicated efforts aimed at increasing 
activity and awareness in public health genomics (CDC, 2013).  While some explorations in the 
human genetic sciences are in their infancy, this very fact brings uncertainties and anxieties that 
are already affecting human health in ways never before seen.  For instance, a genetic test may 
indicate that an individual is susceptible to a particular disease, but a conundrum arises as to 
what to with this knowledge without symptomatic condition or proven treatment options.  Equal 
access to genetic tools is a concern that prevails in contemporary public health policy, parallel to 
the concern about equal access to other medical services.  Without equal access to genetic 
services, social disparities in personal health, already a contemporary public health challenge, 
will be exacerbated.   
 Reproductive genetic technology also poses new public health policy concerns as rapidly 
advancing technology advances are used for reproductive gender selection and selection of non-
diseased embryos for implantation.  Broader application of these genetic technologies raise 
societal implications related to increasing gender choice and imbalances in health prosperity, 
which will compound existing public health challenges and could create new ones.   
 Environmental genomics is a related and compelling contemporary science that directly 
impacts public health policy.  The aim of environmental genomics is to develop predictable 
correlation of response to environmental exposures by genetically susceptible persons.  As this 
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science develops, it will allow for more precise disease/health risk determination and thus more 
targeted, less sweeping and less costly environmental health exposure regulations.    
 As genetic science capabilities continue to advance, guidelines for use of this information 
need to be reflected in public health practice and serve medical treatment modalities.  
Accordingly, public health professionals should be on the front lines of elucidating and 
developing not only genomic science, but also the legal, ethical and social implications of 
genetic determinants of health.   
 Healthy People 2020 (United States Department of Health and Human Services [DHHS], 
2013) contains an objective area for genomics, which was not in Healthy People 2010.  Under 
the “Objectives” section of Healthy People 2020, several future opportunities of genomics in 
public health are recognized.  These opportunities include specifically “[I]ncorporating health-
related genomics education in primary, secondary, undergraduate, and graduate curricula” 
(DHHS, 2013, Emerging Issues in Genomics, line 7).  This paper focuses on current graduate 
curricula and demonstrates a dearth of public health genomics materials in these programs.  An 
introductory, broad topical public health genomics course (e.g., overview of many topics vs. 
deep detail into any one) would help fill this need initially for newly developing public health 
professionals and could be a valuable continuing education offering for established professionals.   
Statement of Purpose 
 The purpose of this culminating experience manuscript is to determine whether public 
health academic programs include adequate curriculum related to current human genetics 
sciences.  To this end, the manuscript will answer the following questions: 
1.  What is the state of genetic science at it relates to Public Health Genomics? 
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2.  Does contemporary Public Health Genomics demonstrate a need to include more 
genomics-related material in standard Masters Public Health curricula? 
3.  What type of Public Health Genomics course would be useful to students’ 
professional development? 
Methods 
 A literature review and synthesis was performed of genetics-related peer-reviewed 
studies and other genetic science related professional source material.  Studies and materials used 
were obtained using key word searches of “genetics,” “genomics,” and “public health”.  
Quantifying analysis was used to illustrate increases in the number and type of genomic studies 
and decreases in cost to perform them.  Prior survey research was assessed related to health care 
providers’ use of genetics in clinical medicine and the public’s use and understanding of genetic 
testing capabilities and results.  An internet and literature search was conducted and critical 
content assessment performed of public health genomics resources and programs at academic 
public health programs in the United States.  Findings were assessed with regard to applications 
of genetics and public health and corresponding existence of public health course curriculum.   
Literature Review 
General Current Status of Genomic Science 
 Healthy People 2020 is the first Healthy People program to include genomics in its 
targeted health outcomes.  The goal is to “improve health and prevent harm through valid and 
useful genomic tools in clinical and public health practice” (DHHS, 2013, Goal, paragraph 1).  
Healthy People 2020 includes genomics because individuals’ genetics play a role in nine out of 
ten leading causes of death, including heart disease, cancer, stroke, diabetes, and Alzheimer’s 
disease (DHHS, 2013, Why Genomics is Important, paragraph 1).  For example, studies show 
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that women who have inherited a disease-causing mutation in the BRCA1 gene have a 55 to 65 
percent risk of developing breast cancer by age 70, and women who have inherited a disease-
causing mutation in the BRCA2 gene have a 45 to 47 percent risk (Chen & Parmigiani, 2007; 
Antoniou, Pharoah, & Narod, 2003).  For women whose genetic tests reveal the gene mutations 
for BRCA 1 and BRCA 2, breast surgery is an early intervention option that could reduce the 
risk of breast cancer by 95 percent (Hartman et al., 1999; Domchek et al., 2010; Rebbeck, 
Friebel, & Lynch, 2004; Meijers-Heijboer, Van Geel, &Van Putten, 2001). 
 The cost of genetic testing and the number of studies performed in recent years is 
relevant to the topic of the current state of genomic science.  Figure 1 shows the cost of genetic 
sequencing since the completion of the Human Genome Project in 2003.  The cost of genetic 
testing has been in a downward spiral since about 2008 (National Institutes of Health [NIH], 
2013a).  Figure 1 shows two metrics related to the cost of DNA sequencing.  The "Cost per 
Megabase of DNA Sequence" is the cost of determining one megabase (Mb; a million bases) of 
DNA sequence.  The "Cost per Genome" is the cost of sequencing a human-sized genome.  The 
cost to sequence per human sized genome in 2007 was an estimated $10 million; in 2012 the 
same test cost under $10 thousand.   
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Figure 1. Cost of genetic synquencing trends.  
Source: NIH, 2013b 
 The cost effectiveness of gene sequencing has been increasing over the last decade due to 
advance in technology such as automation.  Prior to 2008, first generation sequencing platforms 
were used, and after 2008 new second generation sequencing platforms became available.  These 
advancements have been driven by a competitive market to reduce costs to the point where 
genetic testing could be used in individual’s routine medical care (Shendure, Mitra, Varma, & 
Church, 2004).  Today, direct-to-consumer (DTC) genetic testing companies, such as 23andMe 
(2013) provide personal genetic testing for $99.001.  The orders for these tests are placed entirely 
on-line at a computer with salivary DNA samples sent to the company via standard mail. 
 Figure 2 shows the total number of genome-wide research studies published from years 
2004 to 2012.  There is a notable upward trend beginning in 2008, the same year that the cost of 
genetic testing began to substantially decrease.  Literature suggests there is an association 
between the decreased cost of genetic testing and the increase in genetics related studies.  For 
example, Rowell (2013) conducted a study to determine trends in pathogen genetics studies and 
concluded that advances in technology have increased investigations into the role of human 
                                                          
1  Further review of DTC genetic testing is addressed later. 
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genetic variation in the epidemiology of infectious diseases.  Specifically, the study analyzed 
human genome epidemiology articles published from 2001 to 2010 (n=3,730), which included 
23 genome-wide association studies (GWAS).  The number of published articles each year 
increased from 148 in 2001 to 543 in 2010.  Rowell (2013) concluded that as genomic research 
methods become more affordable, population-based research on infectious diseases will expand 
investigations into the role of variation in human genomes and bring new understanding of 
infectious disease susceptibility, severity, treatment, control, and prevention. 
 
Figure 2. Genome-wide research studies published 2004-2012.   
Source: NIH, 2013b 
Personalized Medicine 
 Personalized medicine is the use of genetic testing to advance diagnosis of, or 
predictability for disease, and in turn provide earlier and individually tailored prevention and/or 
treatment intervention.  Such tests are of interest to physicians, researchers, and members of the 
general public who are interested in better understanding their potential for developing specific 
diseases.  It is therefore important for public health professionals to understand the changing 
landscape of tests available for this type of disease risk analysis.  
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 There are about 2,000 genetic tests currently available for clinical use in personalized 
medicine efforts (CDC, 2013).  However, Hamburg and Collins (2010) illustrates that there was 
no single public source of comprehensive information about these tests and whether they were 
cleared or approved by the United States Federal Drug Administration, which made it difficult 
for clinicians and consumers to make informed decisions about the testing to optimize individual 
health care.  This problem was rectified on February 29, 2012, when the NIH started the Genetic 
Testing Registry (GTR), a centralized online resource for information about genetic tests (NIH, 
2012).  The intended audience for the GTR is health care providers and researchers.  
 Genetests is a medical genetic information resource owned by BioReference Laboratories 
created for physicians and geneticists that maintains a directory of laboratories offering genetic 
testing (Genetests.org, 2012).  The organization reports exponential growth in the number of 
diseases tested for with molecular genetic testing.  In 1993 there were approximately 100 clinics 
that tested for about 100 diseases.  In 2012, just over 600 laboratories offered tests for over 2,900 
diseases.   
 Three ways for an individual in the United States to obtain genetic testing include: as a 
patient from a clinical provider; as a research subject in a genetic research study; and, as a 
private consumer through commercial genetic testing companies.  Each of these testing methods 
is reviewed below. 
Clinical setting testing. 
 Despite the number of genetic tests increasingly available for clinical utility, studies 
indicate that health care providers may not be prepared to appropriately offering genetic tests or 
incorporating genetic testing in their clinical practice due to lack of familiarity or knowledge 
(Harvey et al., 2007; Cox et al., 2012).  Harvey et al. (2007) reported that of 5,915 survey 
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respondents, 64% of patients with genetic conditions received no genetic information materials 
from their provider.  Five years later, Cox et al. (2012) randomly surveyed 2,191 cancer 
providers in Oregon to determine genetic testing practices of these clinicians.  Cox surveyed 
providers about their use of ten types of genetic cancer tests.  The survey included a description 
of each genetic test and summary of the evidence-based recommendations published by the 
Evaluation of Genomic Applications in Practice and Prevention (EGAPP), the U.S. Preventive 
Services Task Force (USPSTF), and the National Comprehensive Cancer Network (NCCN).  
The results illustrated a lack of familiarity with the genetic test as the most common reason why 
clinicians did not order certain tests (Cox et al., 2012).  
 Genetic testing through research studies. 
 Various types of federally-funded genomic research studies are on-going in which 
thousands of individuals across the nation are recruited to be volunteer human research 
participants (National Human Genome Research Institute, 2013; Church, 2005; Coriell, 2011).  
Standards for genetic research are implemented by the NIH’s Office of Human Research 
Protections (OHRP).  Nonetheless, due to the breadth and pace of genetic science advanced, 
attendant future risks, clinical utility, and the full realm of ethical considerations are unknown 
(NHGRI, 2013; Church, 2005).  At a minimum, today’s genome testing is believed to carry the 
following possible risks to individuals: Infer paternity or other features of the participant's 
genealogy; possibility of statistical evidence that could affect employment or insurance or the 
ability to obtain financial services for the participant; reveal relatedness to criminals or 
incriminate relatives based on DNA samples used in forensic medicine; use of one’s synthetic 
DNA at a crime scene; reveal propensity for a disease currently lacking effective treatment 
options (Caulfield, 2008; McGuire & Beskow, 2010; Church, 2005).  
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 Direct-to-consumer testing. 
 Direct-to-consumer (DTC) genetic testing is commercial DNA testing that individuals 
may obtain without medical provider involvement and without medical indication.  The tests are 
non-diagnostic and are marketed to provide insight to people about personal genetic traits and 
risk of disease and ancestry (CDC, 2013).  These genetic tests are marked on-line through 
various DTC company websites.  The customer provides a salivary DNA sample to the company 
via regular mail.  Examples of DTC companies are Navigenics (2013), 23andMe (2013) and 
deCODEme (2013).  Unlike DTC kits provided by the National Geographic Society (NGS) 
(2013) and Ancestry.com (2013) that are designed primarily to inform about probably ancestral 
groups, these companies offer genetic profile testing of hundreds of thousands of single 
nucleotide polymorphisms to provide consumers their personal risk of developing various 
disorders compared to the average population risk (Borry, 2010).  Borry’s history of the 
development of the DTC business sets forth that beginning in about 2007, advances in 
technology lowered the cost of testing and in turn proliferated the number of genome-wide 
association studies.  However, there was little availability in the primary healthcare setting for 
testing so private companies began to offer this service to customers commercially.  Borry 
(2010) reports that 2007 and 2008 saw a large number of DTC companies entered the market.  
The author reported finding 12 for-profit Internet companies offering limited susceptibility 
testing in 2003, and by 2009 there were over 30 companies offering some DTC services with a 
few offering whole genome sequencing (Borry, 2010).  The DTC business brings concerns for 
potential consumers regarding credibility and comparability of tests, security of DNA use, 
privacy of genetic risk information, and lack of confidence in non face-to-face genetic 
counseling (Borry, 2010).  Some DTC testing laboratories are voluntarily compliant with 
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Clinical Laboratory Improvement Amendments (CLIA) that establishes quality standards for 
laboratory testing (23andMe, 2013).  However, there is no current Food and Drug Administration 
regulation that standardizes testing and test results analysis at DTC companies.  Thus the value 
of the test results, in particular as they pertain to certain population sectors, remains uncertain 
(CDC, 2013; Aehnbauer, 2011; Borry, 2010). 
Disparities in genetic testing. 
 The literature suggests concern for differential access to and utilization of genetic testing 
among racial and ethnic minorities compared to the majority white population, which may lead 
to compounded health disparities (Hall & Olopade, 2006; Pagan, 2009; Zehnbauer, 2011).  Hall 
and Olopade (2006) report that genome testing research subjects come from a predominantly 
European dissent; minority populations are therefore not well represented in genome reference 
bio-repositories that form the basis for diagnostic genetic testing.2  Zehnbauer’s (2011) report on 
DTC companies showed that DTC companies’ interpretive associated risk reports are based upon 
published scientific research correlating particular genetic variants with a specific disease or 
condition; the majority of these peer-reviewed studies focused on Caucasian populations of 
European ancestry.  Thus, relevance of the interpretation of the genetic tests is questionable for 
people of African, Asian, or Hispanic ancestry.  Pagan (2009) analyzed a 2005 National Health 
Interview Survey (n=25,364), and showed a lack of awareness of genetic testing for cancer 
across racial and ethnic groups.  Specifically, 48% of non-Hispanic whites reported that they 
heard about cancer genetic testing, while only 31% of blacks, 28% of Asians, and 19% of 
Hispanics were aware of genetic testing for cancer risk.  Pagan concluded that culturally-tailored 
approaches are needed to improve awareness amongst minority groups to avoid further disparity 
                                                          
2  Bio-repositories are reviewed on next page. 
NEEDS ASSESSMENT FOR PUBLIC HEALTH GENOMICS EDUCATION  15 
in cancer screening and outcomes.  This type of health education disparity falls well in the 
domain of public health professionals.   
Pharmacogenomics   
 Pharmacogenetics (PGx) is testing that analyzes a patient’s genetic make-up to determine 
the best drug therapy for the particular patient based upon how they are expected to metabolize 
certain medications (NIHGR, 2013).  The use of PGx is meant to improve the safety and 
effectiveness of drug therapies.  Medco Health Solutions, Inc. and the American Medical 
Association (AMA) conducted a nation-wide survey of 10,000 physicians (Medco Health 
Solutions, Inc., 2009).  Only 26% of the physicians reported any type of education in PGx and 
less than half of them (10%) believed they had the necessary information and training to put PGx 
testing to use in their clinical practice. 
Bio-banks 
 In 2009 TIME magazine presented the “Top 10 Ideas Changing the World Right Now” 
(Park, 2009).  Bio-banks was listed as number eight.  Bio-banks (or repositories) are a collection 
of biospecimen samples often linked with individuals’ demographic and/or health information to 
support a systematic approach to research.  Biorepositories are not a new concept: skeletal 
collections and organ/tissue banks are more traditional examples of this practice.  However, 
DNA bio-banks pose interesting research opportunities and ethical challenges as they are 
increasingly used for the developing field of genetic research.   
 There are numerous DNA bio-banks supporting genetic studies in the United States.  For 
example, the Coriell Medical Institute Personalized Collaborative (CPMC) is a genetic study that 
includes DNA banking to advance personalized medicine and PGx (Coriell Institute for Medical 
Research, year).  The CPMC study has 7,500 individual participants whose genetic data is linked 
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to their full medical and family history in the CPMC DNA databank.  These thousands of DNA 
samples are banked for study purposes, and shared with other large DNA banks, such as NIH’s 
Database of Genotypes and Phenotypes (dbGaP), a database at the National Center for 
Biotechnology Information designed to archive and distribute coded genotype, phenotype, 
exposure, and pedigree data from genome-wide association studies (DHHS, 2013).  One of the 
largest bio-banks currently is from the Personal Genome Project (PGP) started at Harvard 
University (Church, 2005).  This long-term project aims to sequence and publicize the complete 
genomes and (anonymized) medical records of 100,000 volunteers in order to help advance 
capabilities in personalized medicine.   
 Like other contemporary genetic banking studies, both CPMC and PGP are largely 
conducted via communications between volunteers and researchers using computer and the 
internet: this demonstrates how advances in technology drive larger databanks and make genetics 
studies easier for scientists to conduct.  These same advantages bring challenging implications in 
data usage and access, data privacy and security and related implications.  There remains no 
federal statutory guidelines on genetic bio-banks with the failure of the 2006 Genomics and 
Personalized Medicine Act (GovTrack, n.d.), which proposed to develop or expand population-
based bio-banks to study genetic factors that influence drug efficacy and to develop usage 
guidelines for genetic bio-banks.   
 From the public health perspective, population-based bio-banking is a growing 
consideration.  State health departments have recognized opportunities to use population-based 
bio-banks to be utilized to identify genes that contribute to human disease.  For example, 
Connecticut’s state health department’s Virtual Office of Genomics stated that the its 
Departments of Public Health should be actively involved in public consultation and in 
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development of related legislation and infrastructure needed to support population-based bio-
banks (Kelly, Stone, Manning, & Swede, 2007).  Brand, Tobias, and Probst-Hensch (2012) 
discuss the use of genome-based bio-banking for public health research, surveillance systems, 
health policy development, individual health information management and effective health 
services.  They report that public health’s role with implications of research deriving from bio-
banks should include establishing an epidemiological research agenda, balancing individual and 
social concerns, and promoting communication among genomics researchers, public health 
agencies, policymakers, and the public.   
Environmental genetics.   
The environmental genetics field of practice is concerned with the interaction between 
genes and the environment and the links to why some people get sick, while others do not 
(OPHG, 2013).  Thus, environmental genetics is the link between the environment and human 
genes.  Of the determinants of health, one’s genetics is the least controllable component.  
However, there would be far reaching public health advantages to better predicting reactions to 
environmental exposures via genetic testing.   
 For example, building on an earlier study by Kalada (2006) and Ritz (2009) reports that 
pesticides plus certain human genetic types may increase risk of Parkinson's disease.  This 
dopamine transporter genetic variant study found that people with a single susceptible allele who 
lived within 500 yards of fields where pesticides commonly used in agriculture3 were used had 
three times increased risk of developing Parkinson’s disease.  People who had two or more 
susceptible alleles had almost a 5-fold increase in risk.  Ritz noted that people who were 
genetically susceptible but had no pesticide exposure showed no increased risk of Parkinson’s.  
The study results suggested that individuals with a particular genetic make-up may be singularly 
                                                          
3The specific pesticides named in the study are maneb and paraquat. 
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sensitive to the neurodegenerative effects of certain pesticides; these findings could have 
implications for residents of agricultural communities as well as farm workers or industrial 
works in plants that produce these pesticides.   
 Environmental health genetics emerged as a viable public health research area in the late 
1990s.  Kelada (2006) reported a list of seventeen proposed genetic effect modifiers of common 
exposures, which he concludes is suggestive of promising actionable findings with further 
research in these areas.  Table 1 shows various studies that specifically assessed particular 
genotype interactions with pesticide exposures.  All but one of these studies took place after the 
costs of genetic sequences began to decline in 2004, further evidence of the association between 
reduced cost of genetic sequence testing and increase in number of genetic studies.  With the 
advances in genome-wide sequencing beginning in 2003, environmental health genetics has 
become more prominent in public health research.  As the numbers and types of environmental 
health studies continue to grow, chronic decease may be better prevented in genetically high-risk 
populations.   
Table 1. 
Environmental Genetics Studies Pertaining to Pesticides and Genetic Type 
Genotype Type Exposure Study 
ABCB1 Organochlorine insecticides Dutheil et al., 2010 
MM PON1-55  Diazinon and Chlorpyrifos Manthripragada et al., 2010 
 Paraquat and Maneb Ritz et al., 2009 confirming 
Kelada, 2006 
P450 2D6  Pesticides Elbaz et al., 2007 
MnSOD Pesticides Fong et al., 2007 
NQ01 Pesticides Fong et al., 2007 
Combined MnSOD/NQO1 Pesticides Fong et al., 2007 
 Paraquat and Maneb Kelada et al., 2006 
CYP 2D6 29B+ allele  Pesticides Hubble, 1998 
 
 With the increasing development of environmental health genetics science, there are 
several related public health policy considerations.  Resnik (2005) has identified several 
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developing policy areas related to public health genetics.  They include: Should public health 
departments offer genetic tests?  Should genetic tests only be offered to those in known 
environmentally risky areas?  Should public health warn the public when predictive tests do 
evolve?  Should product industry warn the public of possible genetic risks linked to their 
product?  Should genetic tests be mandated for vulnerable groups, such as children?  Should 
products be regulated differently regarding genetic links?  Environmental genetics is a 
developing science with many major public health implications.   
Reproductive genetic uses. 
Preimplantation genetic diagnosis (PGD) is a means of detecting genetic disorders prior 
to an embryo being implanted (CDC, 2007).  A single cell is biopsied from the embryos and 
tested before they are implanted.  This allows for selection or de-selection of certain embryos 
prior to establishing pregnancy.  PGD permits detection of genetic abnormalities and detection of 
certain early and late onset diseases.  Thus, PGD helps reduce the number of newborns with or 
susceptible to specific genetic diseases, and avoids many issues related to considerations for 
termination of pregnancy in the later prenatal screening stages.  However, PGD also allows for 
determination of other non-medical traits, such as gender, which introduces additional ethical 
considerations.   
PGD is used by some to choose the sex of the embryo to be implanted as a means of 
family balancing.  Generally, the use of PGD for testing of non-medical traits is controversial.  
Some countries that allow PGD also have legislature concerning PGD that prohibits sex selection 
(Viville & Pergament, 1998; Wells & Delhanty, 2001; Hudson, 2006; Baruch, 2008a).  However, 
the United States permits non-medical PGD sex selection.  There are no federal or state laws that 
directly regulate PGD for sex selection and professional guidelines, such as from the American 
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Society for Reproductive Medicine, are not binding (Deeney, 2013, p. 340).  This leaves fertility 
clinics to devise their own policies on PGD.  According to Hudson (2006) a 2004 survey study of 
almost five thousand Americans showed that nearly 50% of women and 35% of men approved of 
PGD testing for sex selection (p. 1642).  Sidhu (2012) reported that $18,000 was the average cost 
of a gender selection procedure at high-profile clinics with an estimated 4,000 to 6,000 
procedures performed every year.  “Fertility doctors foresee an explosion in sex-selection 
procedures on the horizon, as couples become accustomed to the idea that they can pay to beget 
children of the gender they prefer” (Sidhu, 2012, p.1). 
A 2006 survey of 415 assisted reproductive technology (ART) clinics in the United 
States, showed that 93% of ART clinics that offered in-vitro fertilization (IVF clinics) provided 
PGD services to patients and 42% of these provided PGD for sex-selection in addition to health-
related diagnosis (Baruch, 2008a).  Baruch (2008a) concluded that PGD is widely provided by a 
large majority of United States IVF clinics, including PGD for sex selection.   
 Two other studies obtained direct data from IVF clinics pertaining to PGD outcomes for 
non-medical sex selection.  Gleicherh and Barad (2007) obtained data from an IVF clinic in New 
York of 92 couples using PGD for family balancing between the years 2004-2006.  A total of 56 
male vs. 36 female embryos were selected for implantation.  This study also included ethnicity 
and showed significantly higher male preference in Chinese, Arab/Muslim, and Asian-Indian, 
and for Western ethnicities a slight, but non-significant, preference for females.  Finally, Colls 
(2009) obtained survey data from 246 clinics across the United States and found similar results 
with 127 male vs. 119 female embryos selected.  Again, significant preferences for males were 
found in Chinese and Indian subjects, while a preference for females was found in Western 
subjects.   
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 Related to reproduction and genetics, newborn genetic testing may become another area 
soon to be impacted by advancements in genetic science.  The National Institutes of Health 
(NIH) recently published a news release stating that $25 million dollars would be spent over the 
next five years in the Genomic Sequencing and Newborn Screening Disorders research program 
to explore possibilities of sequencing newborns’ genomes.  The goal is to determine whether 
useful medical information could be obtained by genetic testing beyond current newborn 
screening standards (National Institutes of Health [NIH], 2013c).   
Assessment of Genomics in Public Health Education 
Genomics in academia/public health education.   
A Healthy People 2020 goal related to genomics recognizes several future opportunities 
of genomics in public health.  Among these is: “[I]ncorporating health-related genomics 
education in primary, secondary, undergraduate, and graduate curricula” (DHHS, 2013, line 7). 
 In 1997, the CDC established the Office of Public Health Genomics (OPHG) that 
promotes the integration of genomics into public health research, policy, and practice (see 
www.cdc.gov/genomics).  According to the OPHG, scientific developments over recent years 
have resulted in new potential for health impact.  The 2011 OPHG Stakeholder Consultation 
Priorities Conference Report identifies advancing education in the public health profession 
regarding genomics as one of the 5 year priority items for 2012-2017 (Office of Public Health 
Genomics [OPHG], 2011, p. 17).  The report found that there needs to be “a greater 
understanding by public health professionals of what genome-based knowledge can bring to 
public health practice” (p. 42).  The report specifically recommends: “Incorporate genomics into 
the curricula of medical schools, nursing schools, and schools of public health” (p. 42).  Thus, in 
2012 OPHG developed five-year priorities for public health genomics as well as a specific action 
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plan for genomic implementation in public health practice (CDC, Public Health Genomics 2013 
at a Glance, Section 1, n.d.).   
 In 2003 the Institute of Medicine (IOM) recommended that genetics be added as a new 
content area to be covered by every school of public health.  This recommendation was made 
based upon IOM’s assessment of the broader applications possible within public health of 
genomics versus previous genetic science aimed only at individuals.  Recent personal 
correspondence with the three editors of the 2003 IOM report indicates the document has not 
been updated to determine whether and how the recommendations have been implemented (K. 
Gebbie, personal communication, 28 Oct. 2013; Rosenstock, 2013; L. Hernandez, personal 
communication, 28 Oct. 2013).  Enough time has passed to make these assessments. 
 In 2007 the NIH’s Secretary’s Advisory Committee, Genetics, Health and Science 
(SACGHS) reported that there were 38 schools of public health in the United States that offered 
courses related to genetics or genomics.  Of the 38 public schools, 11 had centers with 
concentrations in genetics or public health genomics and thus had several genetics and genomics 
related courses at these centers.  The other 27 were general public health programs that offered 
one or two genetics related courses. 
 The literature review for this paper found no surveys or other data reporting the extent to 
which U.S. public health programs have incorporated genetics or genomics related courses since 
2007.  The Council on Linkages between Public Health Academia and Practice (housed as the 
Public Health Foundation) and the Association of Schools and Programs in Public Health 
(ASPPH) are two current organizations whose mission interests include public health core 
competencies and education of public health professionals.  A search of these organizations’ 
websites and published materials revealed no surveys of graduate public health education courses 
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related to genetics courses.  In support of this paper, each of these organizations was asked to 
confirm whether they have conducted surveys of public health programs to obtain current data on 
how many programs offer genetics or genomics related courses and to what extent.  The Council 
of Linkages did not respond.  ASPHH responded that they have not and are not aware of any 
such data (Wiest, personal communication, 2013). 
 The Council on Education for Public Health (CEPH) is an independent agency 
recognized by the U.S. Department of Education to accredit schools of public health and public 
health programs outside schools of public health.  On its website, CEPH (n.d.) lists the names of 
100 of its certified public health programs.  During this review, a random selection of twenty of 
the listed public health programs was analyzed for content regarding offering of genetics or 
genomics related courses.  The twenty public health program 2013 curriculums were obtained 
from the respective programs’ websites.  Full course catalogs were not reviewed for alternate 
year courses were not accounted for in this review.  A search of the 2013 course calendar was 
done for any course within the program that used the word “genetics” or “genomics” in the 
course title.  
 Table 2 shows the results of the program and curricula review.  Of the twenty programs, 
none had a concentration in genetics or genomics and none had required courses in the area of 
genetics or genomics.  Four of the ten offered one or two elective courses related to genetics or 
genomics: University of Maryland at Baltimore, University of Cincinnati, Oregon Health and 
Science University, and, New Mexico State University.  While this assessment is not 
representative, it does provide some idea of the lack of genetic content in public health curricula.   
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Table 2 
Twenty CEPH-accredited Public Health Programs and their Genetics or Genomics-related Courses 
Brown University 
Providence, RI 
No mention of genetics or genomics in list of courses 
East Carolina University 
Greenville, NC  
No mention of genetics or genomics in list of courses 
Eastern Kentucky University 
Richmond, KY 
No mention of genetics or genomics in list of courses 
Emory University 
Atlanta, GA 
EH527 Biomarkers and Environmental Public Health 
Jackson State University 
Jackson, MS  
No mention of genetics or genomics in list of courses  
Morgan State University 
Baltimore, MD  
No mention of genetics or genomics in list of courses 
New Mexico State University 
MPH Program in Community 
Health Education 
Las Cruces, NM  
GERO 456. Biological Aspects of Aging.   Aging, the developmental 
process of the body determined by cellular changes influenced by 
lifestyle, genetics, and environment. Investigates these changes, how 
health promotion influences them, and when they are considered a 
disease.  
Northwestern Ohio Consortium for 
PH 
Toledo, OH 
Genetic Epidemiology or Molecular Epidemiology 
Oregon State University 
Portland, OR  
PHPM 507 Genomics and Public Health:  Current Issues and Future 
Trends in Healthcare and Policy 
St. George’s University 
Great River, NY 
No mention of genetics or genomics in listed courses 
San Diego State University 
San Diego, CA 
No mention of genetics or genomics in listed courses 
Temple University 
Philadelphia, PA 
No mention of genetics or genomics in listed courses 
University of Cincinnati Public 
Health Program  
Cincinnati, OH  
PH 7064: Statistical Genetics (2013) 
PH 8056: Environmental Genetics and Molecular Toxicology  
University of Florida 
Gainesville, FL 
No mention of genetics or genomics in listed courses 
University of Iowa 
Iowa City, IA 
EPID5560 Introduction to Molecular Epidemiology 
EPID 5570 Genetics and Epidemiology 
University of Kansas 
Kansas City, KS 
No mention of genetics or genomics in list of courses 
University of Maryland at 
Baltimore MPH Program Baltimore, 
MD  
PREV 711, Genetic Epidemiology  
University of West Florida 
Pensacola, FL  
No mention of genetics or genomics in list of courses  
University of Wisconsin-Madison 
Madison, WI  
No mention of genetics or genomics in list of courses  
Virginia Tech 
Blacksburg, VA  
No mention of genetics or genomics in list of courses 
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Discussion 
 The completion of the National Human Genome Project, current advances in genetic 
testing technologies and the proliferation of scientific research are rapidly increasing the uses of 
human genetic information in medical treatment, reproductive applications, environmental 
genetics and genomics, as well as personal use of genetic testing through commercial enterprise.  
Because each of these areas has implications in public health, public health professionals should 
have working knowledge of this science and its implications.  As indicated in the 2011 IOM 
recommendations, this knowledge should be made available in public health education programs.  
 Published genetic studies have exponentially increased since 2007 while the cost of 
genetic tests decreased.  The association between the lowering cost of genetic testing and 
increase in published studies is reflected in the literature (Rowell, 2013; Borry, 2010; NIH, 
2012).  Consequently, genome-wide sequencing studies are being published and attendant data 
placed in evolving national genetic bio-repositories to more quickly standardize and advance 
genetic science.  Resulting applications and opportunities are reflected in the literature.  
Examples are Rowell’s (2013) report of expansions in infectious disease investigations, Borry’s 
(2010) report of proliferation of consumer use of DTC testing, Ritz’s (2009) report of 
environmental genomics applications, and documentation of increasing uses of genetic testing in 
reproduction (Hudson, 2006; Baruch, 2008b; Colls, 2009).   
 There is no indication that the trend of continued reduced cost, increases in research, and 
expanded use and commercializing of genetic testing is going to end.  If this trend continues, 
genetics and genomics will change modern day medicine and broaden implications to public 
health.   
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 With 2,000 (and counting) clinically relevant genetic tests available to clinicians, 
personalized medicine and pharmacogenomics have profound potential to prevent chronic 
disease, to save life, and to extend life expectancy—all of which are direct public health 
considerations (CDC, 2013).  Early detection and intervention capabilities resulting from genetic 
tests could significantly improve success in preventive medicine, as was demonstrated in the 
BRCA 1 and BRCA 2 gene mutation, where multiple studies reported significant risk reduction 
for breast cancer (Hartman et al., 1999; Domchek et al., 2010; Rebbeck et al., 2004; Meijers-
Heijboer et al., 2001).   
 Public health concerns related to personalized medicine include not only ensuring fair 
and affordable access to genetic testing, but also protection from possible harms of testing.  The 
OPHG website offers public health community awareness initiatives that could help inform 
people about these risks, which may include: depression, anxiety, guilt, family tension, false 
sense of security, unclear results, costly testing and follow-up counseling (American Society of 
Clinical Oncology, 2012).   
 Cost of disease treatment after onset is a contemporary public health challenge that could 
be mitigated by genetics.  It stands to reason the results of personalized medicine through 
genetics and pharmacogenomics would decrease cost of medical care by better targeting 
preventative treatments.  Early detection and preventive treatment will result in fewer expressed 
diseases and disease sequelae.  Tailored prescriptions can mean less trial and error with drugs, 
and thus less cost in pharmaceuticals.   
 The literature review in this paper supports Burke’s six recommendations for the role of 
public health genomics in the “era of personalized medicine,” for public health involvement in 
improving global human health through genomics:   
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 1) Continue to integrate genomics into public health research and practice;  
 2) Establish and maintain appropriate research infrastructure for generating an evidence-
 base for genomic medicine;  
 3) Develop, implement, and evaluate model public health genomics programs and clinical 
 services;  
 4) Promote international collaboration;  
 5) Foster appropriate genetic services and genome-based research;   
 6) Inform programs, research, and strategies in public health genomics by accepted 
 ethical principles and practices (each cited verbatim from Burke et al., 2010, p. 789).   
It is not possible for public health professionals to fulfill these roles if they are not properly 
educated in genomics and the public health applications.   
 Environmental genomics is a compelling contemporary science that directly impacts 
public health because its very aim is to develop predictable correlation of environmental 
exposures to genetically susceptible persons in order to allow for more precise risk determination 
and thus more precise (better targeted, less sweeping and less costly) environmental health 
exposure regulations.  Rowell’s 2013 study determined that trends in pathogen genetic studies 
revealing more knowledge about the role of human genetic variation in the epidemiology of 
infectious diseases.  Kelada’s (2006) and Ritz’s (2009) findings related to exposures to pesticide 
linked to Parkinson’s disease demonstrate the promise of future actionable preventative health 
potentials in environmental genomics applications.  Kelada (2006) makes the case that more 
epidemiological studies are warranted to advance this science.  If public health students are 
exposed early in their academic studies to this area of science, new epidemiologists may be more 
compelled to incorporate genetics into contemporary study designs.  As genetic capabilities 
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continue to advance, it is imperative that guidelines for use of this information be reflected in 
public health practice.  If science and related regulations are to advance, the public health work 
force must be educated in environmental genetics.    
 Reproductive genetic technology poses new significant public health policy concerns as 
technology is used for non-medical treatment purposes such as reproductive gender selection and 
selection of non-diseased embryos for implantation among those who can afford it.  PGD for sex 
selection may be a valuable choice for family balancing, but is wrought with ethical implications 
yet to be resolved.  Broader application of these genetic technologies may bring societal 
implications such as increasing gender choice and health imbalances, all of which will compound 
existing public health challenges and lead to new ones.   
 Contemporary genetic science brings public health issues related to equal access to 
genetic testing and genetic health awareness disparities.  Without equal access to genetic 
services, social disparities in personal health, already a contemporary public health challenge 
will be exacerbated.  The Secretary’s Advisory Committee on Genetics, Health, and Society 
(SACGHS) identified public genetics education as an important priority for public health 
professionals and recommends improvements in education related to genetics and genomics 
literacy (SACGHS, 2013).  The literature review herein revealed areas where public health 
professionals should be concerned about growing disparities.  Table 3 shows a compilation of 
areas where educated public health professionals could work to mitigate genetics and genomics 
related disparities.  These areas include environmental and epidemiological research, public 
education on direct-to-consumer genetic services, facilitation of regulatory advancements on 
public accessibility to reproductive testing involving genetics, and developing and implementing 
culturally tailored awareness approaches related to genetics. 
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Table 3 
Areas of Public Health Disparities Related to Genomics  
Research Primarily uses white population as subjects.  Results in lack of validity for 
clinical treatment, disease risk assessment, and environmental genomics 
applications across racial and ethnic groups.  Mitigation: Educate 
epidemiologists and other genetic researchers to include subjects across 
racial and ethnic groups.  Educate public health policy practitioners to 
implement and enforce research policy of fairness of representation in 
publically funded research.  
Direct-to-Consumer Service Socio-economic challenged may not afford the luxury of purchasing genetic 
tests commercially.  Mitigation: Educate public health policy practitioners 
to implement fair public access to obtain genetic testing.  
Reproductive Testing Elective IVF services are expensive and not covered by medical 
insurance/welfare insurance.  Socio-economic status will result in 
disparities of those obtaining reproductive testing for diseased embryos 
and/or trait selection.  Mitigation: Educate public health policy practitioners 
to implement fair access regulations and usage of genetic reproductive 
technology. 
Awareness Nearly 50% of whites have heard of genetic testing, while 33% or lower of 
other racial and ethnic groups have not (Pegan, 2009).  Lack of awareness 
among minority populations may lead to compounded health disparities.  
Mitigation: Educate public health community awareness practitioners about 
culturally tailored awareness approaches related to genetics. 
 
Discussion of Genomics in Public Health Education 
Professional organizations and national health agencies have repeatedly documented the 
needed to incorporate genetics and genomics in health education--not only medical and nursing 
education, but also public health academic education.  The literature review provides ample 
documentation of leading national health organizations (NIH, IOM, CDC) that have determined 
it imperative for genetics to be included in public health academia.  IOM’s recommendation to 
include genomics in public health academia was published in 2003, yet it appears public health 
genetics related courses are still lacking from CEPH-accredited general public health graduate 
programs.  
 Studies support the need for increased genetics education amongst health professionals.  
Of 10,000 physicians surveyed nation-wide, only 26% of the physicians reported any type of 
education in pharmacogenetics and only 10% of physicians believed they had the necessary 
information and training to put pharmacogenetic testing to use in their clinical practice (Medco 
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Health Solutions, Inc., 2009).  Over 60% of nearly 6,000 cancer patients surveyed were not 
provided genetic testing information from their providers (Harvey et al., 2007).  As recently as 
2012, 2,191 cancer doctors surveyed in Oregon did not perform validated/recommended cancer-
related genetic tests for patients because they lacked familiarity with the tests themselves (Cox et 
al., 2012).  
 A barrier to including genetics in public health core curriculum may very well be 
crowded program curriculum in which genetics competes with other more obvious, well-known 
and popular public health concerns.  Nonetheless, professional literature and studies repeatedly 
demonstrate the lack of genetics in public health education and recommend better inclusion of 
genetics in public health education to fight leading chronic diseases with genetic components and 
to prepare future public health professions for the advanced world of the genetic era.   
Suggested Methods to Incorporate Genomics in Public Health Education 
In order to assess the exact need today regarding gaps of genetics courses in public health 
programs, a comprehensive survey needs to be conducted to more precisely determine the extent 
to which today’s public health students are exposed to genetics and genomics and related public 
health implications.  From these data, public health must develop and incorporate additional 
genomics course material to fill the identified gaps in educational opportunities.   
 One method to influence inclusion of genetics and genomics material in public health 
academic programs is to clearly include genomics within core competencies for public health 
professionals.  Academic programs are geared toward ensuring students are able to perform 
public health core competencies.  If such core competencies include genomics, this in turn would 
motivate schools with public health programs to include more genomics materials in courses to 
better prepare students to fulfill the core competencies related to genomics.   
NEEDS ASSESSMENT FOR PUBLIC HEALTH GENOMICS EDUCATION  31 
 A method to incorporate genetics and genomics material in the case of crowded public 
health curricula, would be to ensure relevant modules are included in existing core courses.  The 
course title survey included in this article did not look at all material/modules within the courses 
offered, so some may already have inclusions related to genetics.  A fuller survey of academic 
programs will solidify this.  There are several possible ways to incorporate genetics in existing 
curricula because genetics and genomics relate to multiple aspects of traditional public health 
courses.   
 For instance, public health communication education and awareness courses could 
include methods of communicating awareness of complex and ever-evolving issues related to 
genetics.  The health communication and awareness education should include aspects of 
disparities related to genetic research subjects and public genetic literacy and awareness of 
genetic testing across cultural lines.  Public health professionals in the area of community 
education and awareness and global health are well positioned to advance awareness of 
genomics, decrease disparities, and increase appropriate genomic services that would save lives 
today (OPHG, 2013). 
 Another example is epidemiology courses could better serve future public health 
professionals if they included information about genome-wide association studies, the inclusion 
(or lack thereof) of minorities in such studies, and the Genetic Testing Registry (GTR) (the 
centralized online resource for information about genetic tests.)  The intended audience for the 
GTR is health care providers and researchers (NIH, 2013d).  Epidemiology courses are also a 
logical place to educate students about environmental genomics and inclusion of genetics in 
environmental health population studies.  The new world of bio-repositories and population-
based bio-banks is also ripe for inclusion in epidemiology education.  Brand and colleagues 
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(2012) make a compelling case for use of genome-based biobanking for public health research 
and surveillance systems.  Epidemiology students should learn that epidemiologists are in a good 
position to include genetics components in their research that can further advance the modern era 
of genomics for the betterment of public health.   
 Public health law, policy, management, and ethics courses could incorporate a plethora of 
genetic and genomics related materials to better educate students.  Courses should educate 
students that public health professionals can and should be on the front lines of exploring and 
developing legal, ethical, and social implications of the genetic determinant of health and 
establishment of related policy.  Policy education topics for genetics derived from the literature 
for this paper include: Fair access policy and services for genetic testing; environmental 
genomics regulation; ethical and legal standards for bio-repositories and use of genetic 
information; development of standards for genetic testing and analysis of test results, in 
particular from direct-to-consumer laboratories providing tests directly to the public without 
medical consultation; regulating use of pre-implantation genetic testing, in particular for late 
onset disease and trait testing.  
 Despite the value and need to include genetics in public health curriculum, the reality is 
that there are different types, sizes and levels of public health certificate and degree programs in 
the United States.  Inclusion of additional material in the curriculum may be more challenging 
for smaller programs.  Small public health education programs may not have the capacity to 
include more education material, let alone embark on courses on genomics or full concentrations 
on genomics.  For these smaller programs, aspects of genomics could be incorporated into 
existing basic, required public health courses where appropriate.  For instance, public health 
introduction courses could include a survey chapter on various aspects of public health 
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genomics.  Environmental health courses could include more dedicated aspects of genomics and 
gene-environment interactions.  Epidemiology courses and Global Health courses could include 
a lesson on genome-wide sequencing, the evolution of this science, and possible disparities of 
representative populations in epidemiological genetic studies.  Health Communication and 
Awareness courses could include a chapter on the unique complexities of public health literacy 
regarding genetics and genomics, due partially to the quickly evolving/changing science.  Public 
health law and policy basic courses could include a class on unique issues related to public health 
genomics evolving policy.  Existing faculty need not have advanced knowledge in the area in 
order to ensure students are exposed to accurate public health genomics material.  Instead, each 
of these classes could highlight the genomics related material by having an expert guest speaker 
in the genomics area discuss the topics in class.   
 Not all students need become public health genomics professionals, but all public health 
professionals and graduating students of public health programs should have a basic working 
understanding of the genetic sciences, today’s applications, and future opportunities for 
genomics to improve public health.  This basic professional competence could be obtained with 
some level of genomics material incorporated in all public health education programs.  
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Appendix - List of Competencies Met in CE 
Tier 1 Core Public Health Competencies 
Domain #1: Analytic/Assessment 
Describe the characteristics of a population-based health problem (e.g., equity, social 
determinants, environment) 
Use methods and instruments for collecting valid and reliable quantitative and qualitative data 
Identify sources of public health data and information 
Identify gaps in data sources 
Adhere to ethical principles in the collection, maintenance, use, and dissemination of data and 
information 
Domain #2: Policy Development and Program Planning 
Gather information relevant to specific public health policy issues 
Describe how policy options can influence public health programs 
Gather information that will inform policy decisions (e.g., health, fiscal, administrative, legal, 
ethical, social, political) 
Domain #3: Communication 
Identify the health literacy of populations served 
Communicate in writing and orally, in person, and through electronic means, with linguistic and 
cultural proficiency 
Participate in the development of demographic, statistical, programmatic and scientific 
presentations 
Domain #4: Cultural Competency 
Recognize the role of cultural, social, and behavioral factors in the accessibility, availability, 
acceptability and delivery of public health services 
Domain #5: Community Dimensions of Practice 
Identify stakeholders 
Describe the role of governmental and non-governmental organizations in the delivery of 
community health services 
Inform the public about  policies, programs, and resources 
Domain #6:Public Health Sciences 
Identify the basic public health sciences (including, but not limited to biostatistics, epidemiology, 
environmental health sciences, health services administration, and social and behavioral health 
sciences) 
Describe the scientific evidence related to a public health issue, concern, or, intervention 
Retrieve scientific evidence from a variety of text and electronic sources 
Discuss the limitations of research findings (e.g., limitations of data sources, importance of 
observations and interrelationships) 
Partner with other public health professionals in building the scientific base of public health 
Domain #7: Financial Planning and Management 
N/A 
Domain #8: Leadership and Systems Thinking 
Describe how public health operates within a larger system 
Identify internal and external problems that may affect the delivery of Essential Public Health 
Services 
Participate in mentoring and peer review or coaching opportunities 
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Concentration Competencies 
Health Promotion and Education: 
Area 1: Assess Needs, Assets and Capacity for Health Education 
1.2 Engage stakeholders to participate in the assessment process 
Area 2: Plan Health Education Programs 
2.2 Select planning model(s) for health education 
2.4 Formulate specific, measurable, attainable, realistic, and time-sensitive objectives 
2.7 Organize health education into a logical sequence 
Area 3: Implement Health Education 
3.1 Identify training needs 
3.2 Develop training objectives 
Area 4: Conduct Evaluation and Research Related to Health Education 
4.9 Disseminate research findings through professional conference presentations 
Area 5: Manage Health Education Programs – N/A 
Area 6: Serve as a health education resource person 
6.6 Develop training plan 
6.8 Use a variety of resources and strategies 
6.10 Provide expert assistance 
6.11 Evaluate the effectiveness of the expert assistance provided 
Area 7: Communicate and advocate for health and health education 
7.1 Lead advocacy initiatives 
7.4 Use evidence-based research to develop policies to promote health 
 
